A recombinant chimeric influenza virus vaccine expressing the consensus H3 hemagglutinin elicits broad hemagglutination inhibition antibodies against divergent swine H3N2 influenza viruses

Yu, J., Sreenivasan, C., Sheng, Z., Zhai, S.-L., Wollman, J. W., Luo, S., Huang, C., Gao, R., Wang, Z., Kaushik, R. S., Christopher-Hennings, J., Nelson, E., Hause, B. M., Li, F., & Wang, D. (2023). A recombinant chimeric influenza virus vaccine expressing the consensus H3 hemagglutinin elicits broad hemagglutination inhibition antibodies against divergent swine H3N2 influenza viruses. Vaccine, 41(42), 6318–6326. https://doi.org/10.1016/j.vaccine.2023.09.007
Authors:
Jieshi Yu
Chithra Sreenivasan
Zhizhang Sheng
Shao-Lun Zhai
Jared W Wollman
Sisi Luo
Chen Huang
Rongyuan Gao
Zhao Wang
Radhey S Kaushik
Jane Christopher-Hennings
Eric Nelson
Ben M Hause
Feng Li
Dan Wang
Affiliated Authors:
Zhizhang Sheng
Author Keywords:
broadly protective vaccine
consensus hemagglutinin
hemagglutination inhibition
swine influenza
Publication Type:
Article
Unique ID:
10.1016/j.vaccine.2023.09.007
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: